<DOC>
	<DOCNO>NCT02034188</DOCNO>
	<brief_summary>Allogeneic human umbilical cord tissue-derived stem cell inject intravenously ( IV ) per day 7 day safe induce therapeutic effect multiple sclerosis ( MS ) patient .</brief_summary>
	<brief_title>Feasibility Study Human Umbilical Cord Tissue-Derived Mesenchymal Stem Cells Patients With Multiple Sclerosis</brief_title>
	<detailed_description>The propose study ass primarily safety secondary efficacy endpoint allogeneic umbilical cord mesenchymal stem cell ( UC-MSC ) administer 20 patient MS . The primary objective trial freedom treatment associate adverse event 4,12 52 week post treatment . Secondary objective efficacy assess baseline , week 12 52 quantified base follow : Neurological assessment MS functional composite assessment comprises Expanded Disability Status Scale ( EDSS ) , expand EDSS ( Rating Neurologic Impairment Multiple Sclerosis , Scripps neurological rating scale ( NRS ) , pace auditory serial addition test ( PASAT ) , nine-hole peg test , 25-foot walking time . Short-form 36 ( SF-36 ) quality life questionnaire gadolinium enhance MRI scan brain cervical spinal cord also perform indicated time point .</detailed_description>
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<criteria>Patients willing sign inform consent capable understanding feature clinical trial . Willing keep weekly diary undergo observation 12 month Nonpregnant patient 1855 year age MS accord revise McDonald criterion meet Poser criterion clinically define MS. EDSS score 2·0 5·5 point assess least 3 month last acute attack MS. Must proof health insurance country residence . Patients evidence active proliferative retinopathy . Patients poorly control diabetes mellitus ( glycated hemoglobin : HbA1C &gt; 8.5 % ) . Patients renal insufficiency ( Creatinine &gt; 2.5 ) failure . Infection evidence white blood cell ( WBC ) count &gt; 15,000 k/cumm and/or temperature &gt; 38 Celsius . History organ transplant . History previous active malignancy , except localise cutaneous basal squamous cell carcinoma carcinoma situ cervix Exercise limiting angina ( Canadian Cardiovascular Society Class 3 Congestive heart failure ( New York Heart Association class 3 Unstable angina Acute ST elevation myocardial infarction ( MI ) within 1month Transient ischemic heart attack stroke within 1 month Severe valvular heart disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>multiple sclerosis</keyword>
	<keyword>umbilical cord</keyword>
	<keyword>mesenchymal</keyword>
	<keyword>stem cell</keyword>
</DOC>